Institutional investors hold a majority ownership of ABMD through the 91.32% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2013, these large investors purchased a net $616.9 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GENEVA CAPITAL MANAGEMENT LTD. Bought 335.9 Thousand shares of Abiomed Inc